Researcher.Life Logo

Journal of Child and Adolescent Psychopharmacology : Impact Factor & More

eISSN: 1557-8992pISSN: 1044-5463

Key Metrics

CiteScore
4.1
H-Index
90
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Child and Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Child and Adolescent Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Child and Adolescent Psychopharmacology

Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Letter: Outcome Measure Selection as a Source of Null Results in Autism Pharmacotherapy: The Case of Brexpiprazole and the ABC-I.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Symptoms Improve for Inpatient Adolescents According to Measurement-Based Care.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Manganese Exposure and Attention-Deficit/Hyperactivity Disorder-Related Neurobehavioral Outcomes in Children: A Systematic Review of Human Studies.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Letter: Outcome Measure Selection as a Source of Null Results in Autism Pharmacotherapy: The Case of Brexpiprazole and the ABC-I.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Symptoms Improve for Inpatient Adolescents According to Measurement-Based Care.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology
Manganese Exposure and Attention-Deficit/Hyperactivity Disorder-Related Neurobehavioral Outcomes in Children: A Systematic Review of Human Studies.
  • 1 Aug 2026
  • Journal of child and adolescent psychopharmacology

FAQs on Journal of Child and Adolescent Psychopharmacology